Evaluation of Desmodium velutinum in the management of Kasa

Evaluation of Desmodium velutinum (WILLD.)DC as a substitute of Shalaparni - Desmodium gangeticum (L.)DC. in the management of Kasa: A Pharmacotherapeutical study - EDVIK

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/06/019662

Enrollment

Registered

2019-06-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J06- Acute upper respiratory infections

Interventions

Intervention1: Desmodium gangeticum (L)DC: Panchang kwath in the dose of 50 ml morning and evening before meal for two weeks Control Intervention1: Desmodium velutinum (WILLD.) DC: Panchang kwath in t

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having cough as a predominant symptom 2. Uncomplicated cases of Kasa. 3. Age group: 18 - 70 yrs. 4. Chronicity less than 1 month.

Exclusion criteria

Exclusion criteria: 1. Age more than 70 years and below 18 years. 2. Patients suffering from any systemic disorder (like Tuberculosis, Asthma, and Diabetes Mellitus etc.) and Kasa as a complication of any disease will be excluded from the study. 3. Asadhya or Yapya Kasa like Kshayaja and Kshataja. 4. Other complicated respiratory diseases having any organic lesion such as tumour or any anatomical defect in airway.

Design outcomes

Primary

Measure	Time frame
Relief in sign and symptoms of KasaTimepoint: 2 weeks	—

Secondary

Measure	Time frame
Objective parametersTimepoint: 2 weeks	—

Countries

India

Contacts

Public ContactVd BR Patel

Institute of Post Graduate Teaching and Research in Ayurveda

brpayu@gmail.com9427574590

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026